Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: J Pharm Pract. 2021 Apr 8:8971900211008261. doi: 10.1177/08971900211008261

Table 1.

Considerations for Specific Types of Maintenance IV Fluid13.

Type of mIVF Example(s) Considerations
Isotonic saline 0.9% NaCl
  • Distributed throughout extracellular fluid compartment

  • High Na+ content may promote Na+ and water retention

  • Supraphysiologic Cl- content may promote hyperchloremia and development of hyperchloremic metabolic acidosis and renal dysfunction1923

  • Not effective to alkalinize urine or plasma

Hypotonic salines 0.45% NaCl, 0.225% NaCl
  • Greater distribution to tissues compared to isotonic crystalloids

  • Risk of hyponatremia

Hypertonic salines 3% NaCl
  • Less distribution to tissues compared with isotonic crystalloids

  • Risk of hypernatremia

  • Generally used in low volumes for sodium replacement or effects on tonicity, not fluid replacement

Dextrose solutions D5W, D10W
  • Fluid distributed throughout total body water

  • Glucose content prevents starvation ketosis

  • Risk of hyponatremia

  • Risk of hyperglycemia

Dextrose-containing crystalloids D5NS, D5LR, D5½NS
  • Glucose content prevents starvation ketosis

  • Risk of hyperglycemia

  • Lower risk of hyponatremia compared to pure dextrose solutions

Balanced crystalloids LR, PlasmaLyte
  • Distributed throughout extracellular fluid compartment

  • Less risk of hyperchloremia compared to 0.9% NaCl

  • Contains other electrolytes that may meet overall maintenance needs

  • Contains 4–5 mEq/L of potassium

  • Risk of lactate accumulation in advanced liver cirrhosis

NaHCO3 50–100 mEq in 1/2NS; 150 mEq in sterile water or D5W
  • Effective plasma and urine alkalinization

  • Risk of metabolic alkalosis

  • Consider patient specific factors when choosing diluent

  • In patients at higher risk or currently hypervolemic, consider no diluent and adjust administration rate.

  • May be helpful in AKI with pH<7.2024 or sepsis with pH<7.1525

  • When used in acidemia, overcorrection of pH may worsen end-organ perfusion26,27

Abbreviations: mIVF, maintenance intravenous fluid; NaCl, sodium chloride; D5W, 5% dextrose in water; D10W, 10% dextrose in water; D5NS, 5% dextrose in 0.9% NaCl; D5LR, 5% dextrose in lactated Ringer’s; D5½NS, 5% dextrose in 0.45% NaCl; LR, Lactated Ringer’s; D5LR, 5% dextrose in lactated Ringer’s.